Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Evogene Schedules Second Quarter 2026 Financial Results Release
07:00am, Thursday, 30'th Jul 2026
Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry,
Collaboration combines Evogene's AI-driven computational chemistry platform with ELEO's proprietary biological capabilities to accelerate the discovery of novel oral therapies targeting a multi-billio
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
07:30am, Wednesday, 15'th Jul 2026
New AI model enables ChemPass AI for Ag™ to identify and prioritize antifungal molecules with a higher probability of biological success at early discovery stages REHOVOT, Israel, July 15, 2026 /P
Supporting Israel's Academic Innovation Ecosystem: BCDD to Provide World-Class Experimental Infrastructure, Evogene to Deliver Computational Chemistry and AI Capabilities REHOVOT, ISRAEL and TEL AVIV,
EverGen Infrastructure Announces Share Issuance to Officers and Directors of the Company
11:00pm, Monday, 06'th Jul 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), announces the grant of deferred share units (“DSUs”) an
Integration of agentic computational systems enables the early-stage definition of key clinical and biological success criteria, accelerating discovery timelines, improving scalability, and increasing
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
07:00am, Tuesday, 09'th Jun 2026
Conference to be held in San Diego, CA, USA – June 22-25, 2026 REHOVOT, Israel, June 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemist
Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical Activity REHOVOT, Israel, June 2, 2026 /PRNewswire/ -- Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a p
EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript
01:14pm, Friday, 29'th May 2026
EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript
EverGen Infrastructure Reports Q1 2026 Results
05:57pm, Thursday, 28'th May 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q1 2026. All
Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
02:00pm, Wednesday, 20'th May 2026
Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
Evogene Reports First Quarter 2026 Financial Results
07:00am, Wednesday, 20'th May 2026
Conference call and webcast: today, May 20, 2026, 9:00 AM ET REHOVOT, Israel, May 20, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry�
Evogene to Present at the 24th Schrödinger European User Group Meeting
08:00am, Tuesday, 12'th May 2026
Conference will be held in Munich, Germany - May 19-21, 2026 REHOVOT, Israel, May 12, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry
Evogene Schedules First Quarter 2026 Financial Results Release
08:00am, Thursday, 07'th May 2026
Zoom conference call scheduled for May 20, 2026, 9:00 AM ET REHOVOT, Israel, May 7, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, spec
EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript
04:41pm, Thursday, 30'th Apr 2026
EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript
